anti-CD19 CAR-T cell / Shanghai Public Health Clinical Center 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
anti-CD19 CAR-T cell / Shanghai Public Health Clinical Center
ChiCTR-ONC-16009567: Anti-CD19 CAR T Cell Immunotherapy for patients with refractory or relapse CD19+ AIDS related lymphoma

Not yet recruiting
N/A
20
 
HAART + Anti-CD19 CAR-T treatment
Shanghai PublicHealth Clinical Center; Shanghai Public Health Clinical Center, Three-year action plan for promoting the clinical skills and innovation in municipal hospitals of Shanghai (2016-2018)
AIDS related lymphoma
 
 

Download Options